Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG –

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG –
RBC Capital analyst Brian Abrahams maintained a Buy rating on NeuBase Therapeutics (NBSE – Research Report) on February 11 and
In a report issued on January 7, Brian Abrahams from RBC Capital maintained a Hold rating on Theratechnologies (THTX –
In a report issued on January 7, Brian Abrahams from RBC Capital maintained a Hold rating on Intercept Pharma (ICPT
In a report issued on January 7, Brian Abrahams from RBC Capital maintained a Hold rating on Enanta Pharmaceuticals (ENTA
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals
Analysts fell to the sidelines weighing in on Galapagos (GLPG – Research Report) and Mesoblast (MESO – Research Report) with